UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...

Privately-held Austria firm pharmaand GmbH (pharma&) today announced that the National Institute of Health and Care Excellence (NICE) has issued a positive recommendation for its Rubraca (rucaparib).

The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...

Blinatumomab represents a major breakthrough in the way the immune system combats cancer cells. This treatment works by helping the body's immune system recognise and destroy any remaining cancer ...

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

Craic Health has secured grant funding for its social prescribing scheme which uses comedy-based interventions to help people ...

BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Craic Health has secured grant funding for its social prescribing scheme which uses comedy-based interventions, such as stand ...

The new National Institutes of Health policy would strip research groups of hundreds of millions of dollars to cover ...

A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS ...

An NHS GP has explained the real reason you might see your doctor open up Google during your appointment - as she insisted it ...